Exit interviews administered to patients participating in the COSTOP placebo controlled randomised trial in Uganda

INTRODUCTION: COSTOP was a randomised controlled trial designed to assess the risks and benefits to HIV-infected participants stabilised on anti-retroviral treatment of stopping cotrimoxazole (CTX). In order to assess the extent to which patients may have had access to and used CTX other than that s...

Full description

Saved in:
Bibliographic Details
Published in:Contemp Clin Trials Commun
Main Authors: Nunn, Andrew, Anywaine, Zacchaeus, Seeley, Janet, Munderi, Paula, Levin, Jonathan, Kasirye, Ronnie, Kamali, Anatoli, Abaasa, Andrew, Grosskurth, Heiner
Format: Artigo
Language:Inglês
Published: Elsevier 2016
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4918030/
https://ncbi.nlm.nih.gov/pubmed/27536738
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.conctc.2016.05.008
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items